Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118
Article CAS PubMed Google Scholar
Daruich A, Matet A, Marchionno L, De Azevedo J-D, Ambresin A, Mantel I et al (2017) Acute central serous chorioretinopathy: factors influencing episode duration. Retina 37:1905–1915
Article PubMed PubMed Central Google Scholar
van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO et al (2019) Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res 73:100770
Erikitola OC, Crosby-Nwaobi R, Lotery AJ, Sivaprasad S (2014) Photodynamic therapy for central serous chorioretinopathy. Eye (Lond) 28:944–957
Article CAS PubMed Google Scholar
Yadav NK, Jayadev C, Mohan A, Vijayan P, Battu R, Dabir S et al (2015) Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: Safety profile and treatment outcome. Eye 29:258–265
Article CAS PubMed PubMed Central Google Scholar
Pitcher JD 3rd, Witkin AJ, DeCroos FC, Ho AC (2015) A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study. Br J Ophthalmol 99:848–852
Lotery A, Sivaprasad S, O’Connell A, Harris RA, Culliford L, Ellis L et al (2020) Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double blind, placebo-controlled trial. Lancet 395:294–303
Article CAS PubMed Google Scholar
Chhablani J, Rani PK, Mathai A, Jalali S, Kozak I (2014) Navigated focal laser photocoagulation for central serous chorioretinopathy. Clin Ophthalmol 8:1543–1547
Article PubMed PubMed Central Google Scholar
Singh SR, Goté JT, Chhablani J (2023) Randomized controlled trials in central serous chorioretinopathy: a review. Eye (Lond). https://doi.org/10.1038/s41433-023-02509-9
Conrad R, Geiser F, Kleiman A, Zur B, Karpawitz-Godt A (2014) Temperament and character personality profile and illness-related stress in central serous chorioretinopathy. Sci World J 2014:631687
Nongrem G, Surve A, Venkatesh P, Sagar R, Yadav RK, Chawla R, Vohra R, Kumar A (2021Dec) Effect of short-term meditation training in central serous chorioretinopathy. Indian J Ophthalmol 69(12):3559–3563
Article PubMed PubMed Central Google Scholar
Yoshioka H, Katsume Y, Akune H (1982) Experimental central serous chorioretinopathy in monkey eyes: Fluorescein angiographic findings. Ophthalmologica 185:168–178
Article CAS PubMed Google Scholar
Kutz I, Borysenko JZ, Benson H (1985) Meditation and psychotherapy: a rationale for the integration of dynamic psychotherapy, the relaxation response, and mindfulness meditation. Am J Psychiatr. 142(1):1e8
Gagrani M, Faiq MA, Sidhu T, Dada R, Yadav RK, Sihota R et al (2018) Meditation enhances brain oxygenation, upregulates BDNF and improves quality of life in patients with primary open angle glaucoma: A randomized controlled trial. Restor Neurol Neurosci 36:741–753
Dada T, Mittal D, Mohanty K, Faiq MA, Bhat MA, Yadav RK et al (2018) Mindfulness meditation reduces intraocular pressure, lowers stress biomarkers and modulates gene expression in glaucoma: a randomized controlled trial. J Glaucoma 27:1061–1067
Dudani AI, Hussain N, Ramakrishnan M, Telang O, Patil VM, Dudani K, Jadhav B, Gholap V (2021) Psychiatric evaluation in patients with central serous chorioretinopathy in Asian Indians. Indian J Ophthalmol 69(5):1204–1207
Article PubMed PubMed Central Google Scholar
Tekin K, Sekeroglu MA, Cankaya AB, Teke MY, Doguizi S, Yilmazbas P (2018) Intravitreal bevacizumab and ranibizumab in the treatment of acute central serous chorioretihopathy: a single center retrospective study. Semin Ophthalmol 33(2):265–270
Azam MA, Katz J, Fashler SR, Changoor T, Azargive S, Ritvo P (2015) Heart rate variability is enhanced in controls but not maladaptive perfectionists during briefmindfulness meditation following stress-induction: a stratified-randomized trial. Int J Psychophysiol Off J Int Organ Psychophysiol 98(1):27–34
Dada T, Ramesh P, Shakrawal J (2020) Meditation: a polypill for comprehensive management of glaucoma patients. J Glaucoma 29(2):133–140
留言 (0)